Ansell Limited (ANSLY)
USD 71.79
(0.0%)
USD 71.79
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.61 Billion USD | -0.9% |
| 2023 | 1.63 Billion USD | -11.71% |
| 2022 | 1.85 Billion USD | -9.28% |
| 2021 | 2.04 Billion USD | 22.31% |
| 2020 | 1.66 Billion USD | 13.83% |
| 2019 | 1.46 Billion USD | 3.53% |
| 2018 | 1.41 Billion USD | 1.44% |
| 2017 | 1.39 Billion USD | 0.59% |
| 2016 | 1.38 Billion USD | 10.87% |
| 2015 | 1.25 Billion USD | -16.26% |
| 2014 | 1.49 Billion USD | 32.16% |
| 2013 | 1.13 Billion USD | -10.39% |
| 2012 | 1.26 Billion USD | -9.53% |
| 2011 | 1.39 Billion USD | 58.19% |
| 2010 | 881.41 Million USD | 1.04% |
| 2009 | 872.35 Million USD | -23.7% |
| 2008 | 1.14 Billion USD | 28.35% |
| 2007 | 890.76 Million USD | 42.89% |
| 2006 | 623.38 Million USD | -1.52% |
| 2005 | 632.97 Million USD | 15.57% |
| 2004 | 547.71 Million USD | -7.45% |
| 2003 | 591.78 Million USD | -16.23% |
| 2002 | 706.43 Million USD | -66.94% |
| 2001 | 2.13 Billion USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 4.6 Billion USD | -9.73% |
| 1996 | 5.1 Billion USD | -1.94% |
| 1995 | 5.2 Billion USD | 2.66% |
| 1994 | 5.07 Billion USD | 19.97% |
| 1993 | 4.22 Billion USD | -2.27% |
| 1992 | 4.32 Billion USD | 14.63% |
| 1991 | 3.77 Billion USD | -5.29% |
| 1990 | 3.98 Billion USD | 16.83% |
| 1989 | 3.41 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 1.61 Billion USD | -0.9% |
| 2024 Q4 | 830.76 Million USD | 99.13% |
| 2024 Q3 | 417.2 Million USD | -46.85% |
| 2024 Q2 | 784.9 Million USD | 100.0% |
| 2024 Q1 | 392.45 Million USD | -51.92% |
| 2023 FY | 1.63 Billion USD | -11.71% |
| 2023 Q1 | 417.65 Million USD | -56.1% |
| 2023 Q2 | 835.3 Million USD | 100.0% |
| 2023 Q3 | 409.9 Million USD | -50.93% |
| 2023 Q4 | 816.27 Million USD | 99.14% |
| 2022 FY | 1.85 Billion USD | -9.28% |
| 2022 Q4 | 951.34 Million USD | 0.0% |
| 2022 Q2 | 1 Billion USD | 0.0% |
| 2021 Q4 | 1.05 Billion USD | 0.0% |
| 2021 FY | 2.04 Billion USD | 22.31% |
| 2021 Q2 | 937.8 Million USD | 0.0% |
| 2020 Q2 | 753.3 Million USD | 0.0% |
| 2020 Q4 | 878.59 Million USD | 0.0% |
| 2020 FY | 1.66 Billion USD | 13.83% |
| 2019 Q4 | 766.03 Million USD | 0.0% |
| 2019 FY | 1.46 Billion USD | 3.53% |
| 2019 Q2 | 1.02 Billion USD | 0.0% |
| 2018 Q2 | 925.49 Million USD | 0.0% |
| 2018 FY | 1.41 Billion USD | 1.44% |
| 2018 Q4 | 1.03 Billion USD | 0.0% |
| 2017 Q2 | 920.17 Million USD | 0.0% |
| 2017 FY | 1.39 Billion USD | 0.59% |
| 2017 Q4 | 924.43 Million USD | 0.0% |
| 2016 Q2 | 1.07 Billion USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | 1.38 Billion USD | 10.87% |
| 2015 Q4 | 1.03 Billion USD | 0.0% |
| 2015 Q2 | 1.03 Billion USD | 0.0% |
| 2015 FY | 1.25 Billion USD | -16.26% |
| 2014 Q1 | 313.32 Million USD | -60.21% |
| 2014 Q2 | 786.73 Million USD | 151.09% |
| 2014 Q3 | 389.83 Million USD | -50.45% |
| 2014 FY | 1.49 Billion USD | 32.16% |
| 2014 Q4 | 940.1 Million USD | 141.16% |
| 2013 Q4 | 787.47 Million USD | 125.31% |
| 2013 FY | 1.13 Billion USD | -10.39% |
| 2013 Q1 | 316.66 Million USD | 0.0% |
| 2013 Q2 | 349.45 Million USD | 10.36% |
| 2013 Q3 | 349.51 Million USD | 0.02% |
| 2012 Q2 | 326.02 Million USD | 9.76% |
| 2012 Q4 | - USD | -100.0% |
| 2012 FY | 1.26 Billion USD | -9.53% |
| 2012 Q1 | 297.04 Million USD | 0.0% |
| 2012 Q3 | 316.56 Million USD | -2.9% |
| 2011 Q1 | 297.89 Million USD | 0.0% |
| 2011 FY | 1.39 Billion USD | 58.19% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q3 | 315.26 Million USD | 3.95% |
| 2011 Q2 | 303.29 Million USD | 1.81% |
| 2010 FY | 881.41 Million USD | 1.04% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 282.85 Million USD | 3.18% |
| 2010 Q1 | 294.59 Million USD | 0.0% |
| 2010 Q2 | 274.12 Million USD | -6.95% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | 872.35 Million USD | -23.7% |
| 2009 Q1 | 239.85 Million USD | 0.0% |
| 2009 Q2 | 218.81 Million USD | -8.77% |
| 2009 Q3 | 239.37 Million USD | 9.4% |
| 2008 FY | 1.14 Billion USD | 28.35% |
| 2008 Q3 | 285.44 Million USD | 2.02% |
| 2008 Q2 | 279.78 Million USD | 2.3% |
| 2008 Q1 | 273.5 Million USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2007 Q1 | 213 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 250.7 Million USD | 4.45% |
| 2007 Q2 | 240.01 Million USD | 12.68% |
| 2007 FY | 890.76 Million USD | 42.89% |
| 2006 FY | 623.38 Million USD | -1.52% |
| 2006 Q1 | 208.27 Million USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q2 | 213.65 Million USD | 2.58% |
| 2006 Q3 | 202.41 Million USD | -5.26% |
| 2005 Q1 | 200.93 Million USD | 0.0% |
| 2005 FY | 632.97 Million USD | 15.57% |
| 2005 Q2 | 211.96 Million USD | 5.49% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q3 | 211.14 Million USD | -0.39% |
| 2004 FY | 547.71 Million USD | -7.45% |
| 2004 Q2 | 213.34 Million USD | -3.37% |
| 2004 Q1 | 220.79 Million USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q3 | 211.37 Million USD | -0.93% |
| 2003 FY | 591.78 Million USD | -16.23% |
| 2003 Q2 | 190.01 Million USD | -37.14% |
| 2003 Q1 | 302.3 Million USD | 0.0% |
| 2003 Q4 | - USD | -100.0% |
| 2003 Q3 | 194.11 Million USD | 2.16% |
| 2002 Q4 | - USD | -100.0% |
| 2002 Q3 | 295.15 Million USD | 4.45% |
| 2002 FY | 706.43 Million USD | -66.94% |
| 2002 Q1 | 511.41 Million USD | 0.0% |
| 2002 Q2 | 282.57 Million USD | -44.75% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | 2.13 Billion USD | 0.0% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q3 | 509.39 Million USD | -10.97% |
| 2001 Q2 | 572.18 Million USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | -100.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | 1.11 Billion USD | 0.0% |
| 1998 Q2 | - USD | -100.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q3 | 1.2 Billion USD | 2.31% |
| 1997 Q1 | 1.27 Billion USD | 0.2% |
| 1997 FY | 4.6 Billion USD | -9.73% |
| 1997 Q2 | 1.17 Billion USD | -7.85% |
| 1996 Q1 | 1.37 Billion USD | 5.73% |
| 1996 FY | 5.1 Billion USD | -1.94% |
| 1996 Q2 | 1.21 Billion USD | -11.79% |
| 1996 Q3 | 1.26 Billion USD | 4.06% |
| 1996 Q4 | 1.27 Billion USD | 1.03% |
| 1995 Q3 | 1.33 Billion USD | -3.37% |
| 1995 Q4 | 1.3 Billion USD | -2.34% |
| 1995 FY | 5.2 Billion USD | 2.66% |
| 1995 Q1 | 1.28 Billion USD | 1.58% |
| 1995 Q2 | 1.37 Billion USD | 7.09% |
| 1994 Q1 | 1.01 Billion USD | -3.57% |
| 1994 FY | 5.07 Billion USD | 19.97% |
| 1994 Q4 | 1.26 Billion USD | 3.49% |
| 1994 Q2 | 1.23 Billion USD | 21.18% |
| 1994 Q3 | 1.22 Billion USD | -0.8% |
| 1993 Q3 | 1.1 Billion USD | 3.72% |
| 1993 Q4 | 1.05 Billion USD | -4.5% |
| 1993 FY | 4.22 Billion USD | -2.27% |
| 1993 Q2 | 1.06 Billion USD | 2.64% |
| 1993 Q1 | 1.03 Billion USD | -3.88% |
| 1992 Q4 | 1.08 Billion USD | -2.8% |
| 1992 FY | 4.32 Billion USD | 14.63% |
| 1992 Q1 | 980.5 Million USD | 3.93% |
| 1992 Q2 | 1.08 Billion USD | 10.72% |
| 1992 Q3 | 1.11 Billion USD | 2.49% |
| 1991 Q3 | 952.88 Million USD | -1.11% |
| 1991 Q4 | 943.47 Million USD | -0.99% |
| 1991 Q2 | 963.57 Million USD | -7.76% |
| 1991 FY | 3.77 Billion USD | -5.29% |
| 1991 Q1 | 1.04 Billion USD | 4.87% |
| 1990 Q1 | 873.96 Million USD | 2.5% |
| 1990 Q2 | 971.41 Million USD | 11.15% |
| 1990 Q3 | 948.69 Million USD | -2.34% |
| 1990 Q4 | 996.14 Million USD | 5.0% |
| 1990 FY | 3.98 Billion USD | 16.83% |
| 1989 Q2 | 993.55 Million USD | 0.0% |
| 1989 FY | 3.41 Billion USD | 0.0% |
| 1989 Q4 | 852.64 Million USD | -7.21% |
| 1989 Q3 | 918.92 Million USD | -7.51% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -50638.311% |
| Ansell Limited | 1.61 Billion USD | 0.0% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -776.968% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1198893.003% |
| Psykey, Inc. | 419.29 Thousand USD | -386092.192% |
| ConvaTec Group Plc | 2.19 Billion USD | 26.195% |
| ConvaTec Group Plc | 2.14 Billion USD | 24.417% |
| Encision Inc. | 6.58 Million USD | -24487.443% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -88632.414% |
| LifePoint, Inc. | -18.5 Thousand USD | 8753072.973% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -23667.797% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -209653.886% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -164092.574% |
| Reflect Scientific, Inc. | 1.08 Million USD | -149813.809% |
| SmileDirectClub, Inc. | 470.74 Million USD | -243.988% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 13.481% |
| SheerVision, Inc. | 3.49 Million USD | -46173.554% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -116707.834% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -217228.575% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -1552693.84% |